- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02048826
FINGER Robot Therapy Study
March 23, 2021 updated by: David Reinkensmeyer, University of California, Irvine
Study of Influence of Timing on Motor Learning
The purpose of this study is to determine the effectiveness of training hand movement using FINGER robot after stroke.
FINGER is a robot that measures finger movements and allows users to play computer games using those movements.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Robotic devices can be used to retrain movement after stroke.
However, it is unclear how best to assist in movement.
Providing physical assistance may improve the flow of proprioceptive information to the nervous system, which may help a person relearn to move a limb.
On the other hand, assisting movement with a robot may cause a person to "slack", not trying as hard during therapy.
This study will test the effect of different levels of assistance on recovery of finger function during robot-assisted therapy after stroke.
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Irvine, California, United States, 92697
- University of California, Irvine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 to 80 years of age
- Have history of stroke affecting the arm, at least 6 months prior to enrollment
- have arm and/or hand weakness as measured on a standard clinical scale
- do not have active major psychological problems, or problems affecting the stroke-affected arm or hand besides the stroke
- do not have active major brain disease other than the stroke
- have absence of pain in the stroke-affected arm and hand
Exclusion Criteria:
- severe stiffness of the arm or hand as measured on a standard clinical scale
- severe problems speaking or understanding speech as measured on a standard clinical scale
- severe reduced level of consciousness
- severe loss ability to sense movement of your limbs as measured on a standard clinical scale
- currently pregnant
- difficulty in understanding or complying with the instructions given by the researcher
- inability to perform the experimental task that will be studied
- increased pain with movement of the stroke-affected arm or hand
Exclusion criteria that will prevent subjects from participating in the MRI:
- Subjects having any implanted metal such as metallic splinters, metallic surgical clips, prosthetic heart valves, pacemakers, neuro-stimulation devices, orthodontic work that contains ferromagnetic materials,
- Subjects whose occupation or activities may cause accidental lodging of ferromagnetic materials, or that may have imbedded metal fragments from military activities, unless cleared by a screening head CT scan
- Subjects with tattoo(s) presenting metallic or ferromagnetic color ingredients or with facial make-up
- Subjects who have claustrophobia
- Subjects who are currently pregnant or breastfeeding.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FINGER I
Subjects participate in 3 weeks of exercising with the experimental device: FINGER robot with first setting at a minimum of 3 days per week, 1 hour per day with the exercise program
|
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements.
Patients will be exercising with FINGER using setting I
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements.
Patients will be exercising with FINGER using setting II
|
|
Experimental: FINGER II
Subjects participate in 3 weeks of exercising with the experimental device: FINGER robot with a second setting at a minimum of 3 days per week, 1 hour per day with the exercise program
|
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements.
Patients will be exercising with FINGER using setting I
FINGER is a robot that measures finger movements and allows patients to play computer game using those movements.
Patients will be exercising with FINGER using setting II
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor and Strength Outcome Measure Using Box and Block Test Measured in Units of Blocks Placed
Time Frame: From baseline to 1-month post therapy
|
The primary endpoint was the change in Box and Blocks score, which measures how many blocks a subject can pick up and place in a box in 60 seconds, from baseline to 1-month post-therapy.
The higher the scores, the better arm and hand function indicated.
|
From baseline to 1-month post therapy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor and Strength Measure Using Action Research Arm Test Measured as a Score
Time Frame: From baseline to 1-month post therapy
|
We compared the change in Action Research Arm Test (ARAT) scores from the baseline evaluation to 1-month post-therapy evaluation.
The ARAT is a 57-point scale, 0 being the minimum scoreand 57 being the maximum score, that measures upper extremity function, coordination, and dexterity.
The higher scores indicate a better outcome.
|
From baseline to 1-month post therapy
|
|
Motor, Strength and Sensory Using Fugl-Meyer Test Measured as a Score
Time Frame: From baseline to 1-month post therapy
|
The primary outcome measure was the change in Upper Extremity Fugl-Meyer score on a scale of 0 to 66 at one-month post-therapy.
The higher the scores, the better arm and hand function indicated.
|
From baseline to 1-month post therapy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Reinkensmeyer, PhD, University of California, Irvine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
February 1, 2016
Study Registration Dates
First Submitted
January 27, 2014
First Submitted That Met QC Criteria
January 27, 2014
First Posted (Estimate)
January 29, 2014
Study Record Updates
Last Update Posted (Actual)
March 25, 2021
Last Update Submitted That Met QC Criteria
March 23, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HS#2008-6432
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebrovascular Accident
-
China Medical University HospitalRecruitingCerebrovascular Accident (CVA)Taiwan
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...CompletedStroke | Vascular Accident, Brain | Stroke, Acute | Cerebrovascular Accident | Cerebral Stroke | Cerebrovascular Stroke | Cerebrovascular Accident, Acute | Apoplexy | CVA | Cerebrovascular ApoplexyCanada
-
Sheba Medical CenterCompletedLate Effects of Cerebrovascular Accident
-
Universitaire Ziekenhuizen KU LeuvenCompletedTranscranial Direct Current Stimulation | Cerebrovascular Accident (CVA)Belgium
-
Sunnyview Rehabilitation HospitalCompletedStroke | Stroke, Acute | Cerebrovascular Accident | Cerebrovascular Accident, AcuteUnited States
-
Peking University Third HospitalAstraZeneca Investment (China) Co., LtdCompletedCerebrovascular Accident | Cerebrovascular Accident, AcuteChina
-
Medical University of South CarolinaIcahn School of Medicine at Mount SinaiCompletedIschemic Cerebrovascular AccidentUnited States
-
John DavidsonWashington University School of MedicineWithdrawnIschemic Cerebrovascular AccidentUnited States
-
University of California, IrvineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingStroke, Ischemic | Cerebrovascular Accident (CVA)United States
-
Fondation Ophtalmologique Adolphe de RothschildNot yet recruiting
Clinical Trials on FINGER I
-
British University In EgyptRecruiting
-
Centre Hospitalier Departemental VendeeCompletedNutritive ValueFrance
-
Endeavor HealthCompletedHypermobility of Interphalangeal Joints | Swan-Neck DeformityUnited States
-
Loewenstein HospitalTechnion, Israel Institute of TechnologyRecruiting
-
Ataturk UniversityNot yet recruiting
-
Biruni UniversityCompleted
-
University of California, IrvineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingStroke, Ischemic | Cerebrovascular Accident (CVA)United States
-
Amasya UniversityMustela FoundationEnrolling by invitation
-
Hospital Privado de Comunidad de Mar del PlataCompleted